Back to News
Market Impact: 0.12
Inventiva Names Chris Benecchi As COO Ahead Of Lanifibranor's Phase 3 Readout
Source: Nasdaq
Healthcare & BiotechManagement & Governance
Inventiva S.A. (IVA) appointed Chris Benecchi as Chief Operating Officer (COO). The update is operational and governance-focused, with no stated financial targets, trial results, or guidance changes.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
IVEVF0.15
More News
- FDA approves Enspryng for thyroid eye disease treatment
- Supermicro promised a new CFO in December 2024. A $2.5 billion smuggling case and a co-founder’s arrest later, it has one
- Bank of America had to bring in 1,000 contractors to patch all the bugs Mythos identified
- Faraday Copper completes acquisition of BHP’s San Manuel project
- Anduril CEO defends Trump administration contracts: 'We've done incredibly well under Biden'
- Trump administration advances plan for peptide drugs favored by RFK Jr.